Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Tipo de estudo
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Assist Reprod Genet ; 40(10): 2385-2390, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37566317

RESUMO

Turner syndrome (TS) leads to a characteristic phenotype, including premature ovarian insufficiency and infertility. Ovarian tissue cryopreservation (OTC) is becoming an established fertility preservation strategy for both pre- and post-pubertal females and may offer the chance of having a biological family to selected patients with TS. To date, women with TS have had ovarian tissue cryopreserved but there are few reports of autologous re-implantation and none of pregnancy. We herein report, to our knowledge, the first clinical pregnancy in a patient with TS, conceived naturally following re-implantation of cryopreserved ovarian tissue which had been removed soon after spontaneous puberty. This provides proof of concept for OTC as a means of fertility preservation in TS.


Assuntos
Preservação da Fertilidade , Insuficiência Ovariana Primária , Síndrome de Turner , Gravidez , Humanos , Feminino , Síndrome de Turner/genética , Criopreservação , Insuficiência Ovariana Primária/etiologia
2.
J Assist Reprod Genet ; 33(12): 1615-1620, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27639996

RESUMO

With the improvement of long-term cancer survival rates, growing numbers of female survivors are suffering from treatment-related premature ovarian insufficiency (POI). Although pre-treatment embryo and oocyte storage are effective fertility preservation strategies, they are not possible for pre-pubertal girls or women who cannot delay treatment. In these cases, the only available treatment option is ovarian cortex cryopreservation and subsequent re-implantation. A 32-year-old woman had ovarian cortex cryopreserved 10 years previously before commencing high-dose chemotherapy and undergoing a haematopoietic stem cell transplant for recurrent adult Wilms tumour, which resulted in POI. She underwent laparoscopic orthotopic transplantation of cryopreserved ovarian cortex to the original site of biopsy on the left ovary. She ovulated at 15 and 29 weeks post-re-implantation with AMH detectable, then rising, from 21 weeks, and conceived naturally following the second ovulation. The pregnancy was uncomplicated and a healthy male infant was born by elective Caesarean section at 36+4 weeks gestation. This is the first report of ovarian cortex re-implantation in the UK. Despite the patient receiving low-risk chemotherapy prior to cryopreservation and the prolonged tissue storage duration, the re-implantation resulted in rapid restoration of ovarian function and natural conception with successful pregnancy.


Assuntos
Preservação da Fertilidade , Transplante de Células-Tronco Hematopoéticas , Complicações Neoplásicas na Gravidez , Tumor de Wilms/terapia , Adulto , Criopreservação , Feminino , Gametogênese/genética , Humanos , Nascido Vivo , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/terapia , Oócitos/crescimento & desenvolvimento , Oócitos/patologia , Ovário/crescimento & desenvolvimento , Ovário/patologia , Gravidez , Reino Unido , Tumor de Wilms/complicações , Tumor de Wilms/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA